(Q39255407)

10 September 2017

title

Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting (English)

1 reference

10 September 2017

0 references

1 reference

R Seda Tığlı Aydın

1

1 reference

10 September 2017

publication date

20 October 2012

1 reference

Journal of Biomedical Materials Research Part A

10 September 2017

published in

1 reference

10 September 2017

volume

101

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

1405-1415

1 reference

Modelling breast cancer: one size does not fit all.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Paclitaxel nanoparticles for the potential treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Trastuzumab--mechanism of action and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Immunological Approaches in the Treatment of Metastasized Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Potent antibody drug conjugates for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Cancer stem cells: Invitation to a second round

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Targeting the function of the HER2 oncogene in human cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

Delivering nanomedicine to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.34448

21 January 2018

Identifiers

DOI

10.1002/JBM.A.34448

1 reference

10 September 2017

1 reference